Sphingolipids in prostate cancer prognosis: integrating single-cell and bulk sequencing

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Stratifying patient risk is crucial for prostate cancer management.
• Understanding the tumor microenvironment is essential for advancing prostate cancer research.

Purpose of the Study:

• To identify key genes in prostate cancer pathogenesis.
• To develop a prognostic model for risk stratification.
• To explore the role of sphingolipid metabolism in prostate cancer.

Main Methods:

• Integrative analysis of single-cell and bulk transcriptome data.
• Weighted gene coexpression network analysis (WGCNA) for gene module identification.
• Prognostic model development using Cox and LASSO regression.

Main Results:

• A five-gene prognostic model (SRSR) for sphingolipid metabolism was constructed.
• The SRSR model effectively stratified patients into high- and low-risk groups.
• Distinct differences in the immune microenvironment were observed between risk groups.

Conclusions:

• The SRSR model shows promise for improving prostate cancer risk stratification and patient outcomes.
• Sphingolipid metabolism plays a significant role in prostate cancer diagnosis and treatment.
• Further research can leverage this model for clinical applications.